The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model
Open accessAbstract
Background Previous studies have demonstrated reexpression of cell-cycle markers within postmitotic neurons in neurodegenerative tauopathies, including Alzheimer's disease (AD). However, the critical questions of whether cell-cycle activation is causal or epiphenomenal to tau-induced neurodegeneration and which signaling pathways mediate cell-cycle activation in tauopathy remain unresolved. Results Cell-cycle activation accompanies wild-type and mutant tau-induced neurodegeneration in Drosophila, and genetically interfering with cell-cycle progression substantially reduces neurodegeneration. Our data support a role for cell-cycle activation downstream of tau phosphorylation, directly preceding apoptosis. We accordingly show that ectopic cell-cycle activation leads to apoptosis of postmitotic neurons in vivo. As in AD, TOR (target of rapamycin kinase) activity is increased in our model and is required for neurodegeneration. TOR activation enhances tau-induced neurodegeneration in a cell cycle-dependent manner and, when ectopically activated, drives cell-cycle activation and apoptosis in postmitotic neurons. Conclusions TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model, identifying TOR and the cell cycle as potential therapeutic targets in tauopathies and AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pan-neuronal transgenic expression of an FTDP-17 mutant form of human tau, tauR406W, in Drosophila causes progressive neurodegeneration and provides a well-characterized in vivo genetic model of tau neurotoxicity7,15,16.”
From Tau promotes neurodegeneration through global chromatin relaxation (2014) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“No statistical methods were used to predetermine sample sizes but our sample sizes are similar to those reported in previous publications 7,16,44.”
From Tau promotes neurodegeneration through global chromatin relaxation (2014) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in Drosophila indicate that cell cycle activation is causal for neuronal death in tauopathy, and that activation of the cell cycle in neurons is sufficient to induce neuronal death18.”
From Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies (2018) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in Drosophila indicate that cell cycle activation is causal for neuronal death in tauopathy, and that activation of the cell cycle in neurons is sufficient to induce neuronal death18.”
From Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies (2018) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Self-citationThe tor pathway: a target for cancer therapy
Bjornsti, M., & Houghton, P. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1362 · Cited by 1,318
Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Role and Regulation of Starvation-Induced Autophagy in the Drosophila Fat Body
Scott, R. C., Schuldiner, O., & Neufeld, T. P. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.07.009 · Cited by 979
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939
Self-citationA conditional tissue-specific transgene expression system using inducible GAL4
Osterwalder, T., Yoon, K. S., White, B. H., & Keshishian, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221303298 · Cited by 804
Drosophila S6 kinase: a regulator of cell size.
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 785
Expanded Polyglutamine Protein Forms Nuclear Inclusions and Causes Neural Degeneration in Drosophila
Warrick, J. M., Paulson, H. L., Gladys L Gray-Board, Bui, Q. T., Fischbeck, K. H., Pittman, R. N., & Bonini, N. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81200-3 · Cited by 669
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D., & Herrup, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 609
Oxidative stress, cell cycle, and neurodegeneration
Klein, J. A., & Ackerman, S. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18182 · Cited by 584
Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control
Oldham, S., & Hafen, E. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00042-9 · Cited by 547
Self-citationEctopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543
Pharmacological inhibitors of cyclin-dependent kinases
Knockaert, M., Greengard, P., & Meijer, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02071-0 · Cited by 539
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 2×
“The issue of causality has previously been unresolved, although important studies have documented aberrant neuronal cell-cycle markers in human tauopathies and, more recently, in a mouse tauopathy model [36].”
Jackson, G. R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C. A., Massachi, S., & Geschwind, D. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00706-7 · Cited by 488
Billingsley, M. L., & Kincaid, R. L. (1997) · Biochemical Journal · doi:10.1042/bj3230577 · Cited by 466
Griffin, R. J., Moloney, A., Kelliher, M., Johnston, J. A., Ravid, R., Dockery, P., O'Connor, R., & O'Neill, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02949.x · Cited by 459
Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior
Mattson, M. P., Chan, S. L., & Duan, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00004.2002 · Cited by 440
Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein
Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L., & Muchowski, P. J. (2003) · Science · doi:10.1126/science.1090389 · Cited by 422
Giovanni, S. D., Movsesyan, V. A., Ahmed, F. A. K. M., Černak, I., Schinelli, S., Stoica, B. A., & Faden, A. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500989102 · Cited by 380
Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage
Kruman, I. I., Wersto, R. P., Cardozo‐Pelaez, F., Smilenov, L. B., Chan, S. L., Chrest, F. J., Emokpae, R., Gorospe, M., & Mattson, M. P. (2004) · Neuron · doi:10.1016/s0896-6273(04)00017-0 · Cited by 371
Nishimura, I., Yang, Y., & Lu, B. (2004) · Cell · doi:10.1016/s0092-8674(04)00170-9 · Cited by 324
de Nooij, J. C., Letendre, M. A., & Hariharan, I. K. (1996) · Cell · doi:10.1016/s0092-8674(00)81819-x · Cited by 318
An, W.-L., Cowburn, R. F., Li, L., Braak, H., Alafuzoff, I., Iqbal, K., Iqbal, I.-G., Winblad, B., & Pei, J.-J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63687-5 · Cited by 312
Smith, P. D., Crocker, S. J., Jackson-Lewis, V. R., Jordan‐Sciutto, K. L., Hayley, S. P., Mount, M. P., O'Hare, M. J., Callaghan, S. M., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 310
Cell cycle regulation of neuronal apoptosis in development and disease
Becker, E. B. E., & Bonni, A. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.12.005 · Cited by 303
Cdc2 Phosphorylation of BAD Links the Cell Cycle to the Cell Death Machinery
Konishi, Y., Lehtinen, M. K., Donovan, N., & Bonni, A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00524-5 · Cited by 291
Cyclin-dependent kinases as a therapeutic target for stroke
Osuga, H., Osuga, S., Wang, F., Fetni, R., Hogan, M. J., Slack, R. S., Hakim, A. M., Ikeda, J., & Park, D. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170144197 · Cited by 282
Genetic modifiers of tauopathy in Drosophila
Shulman, J. M., & Feany, M. B. (2003) · Genetics · doi:10.1093/genetics/165.3.1233 · Cited by 256
Self-citationRole of Cell Cycle Regulatory Proteins in Cerebellar Granule Neuron Apoptosis
Padmanabhan, J., Park, D. S., Greene, L. A., & Shelanski, M. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08747.1999 · Cited by 233
Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?
Copani, A., Copani, A., Sortino, M. A., Nicoletti, F., Bruno, V., Nicoletti, F., Uberti, D. L., & Memo, M. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01663-5 · Cited by 230
Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases
Husseman, J. W. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00221-9 · Cited by 187
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
Ogawa, O., Zhu, X., Lee, H., Raina, A. K., Obrenovich, M. E., Bowser, R. P., Ghanbari, H. A., Castellani, R. J., Perry, G. L., & Smith, M. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0684-3 · Cited by 175
DrosophilaRheb GTPase is required for cell cycle progression and cell growth
Patel, P. H., Thapar, N., Guo, L., Martinez, M., Maris, J. M., Gau, C., Lengyel, J. A., & Tamanoi, F. (2003) · Journal of Cell Science · doi:10.1242/jcs.00661 · Cited by 152
Regulation of Neuronal Survival and Death by E2F-Dependent Gene Repression and Derepression
Liu, D. X., & Greene, L. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00495-0 · Cited by 133
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
Scherzer, C. R., Jensen, R. V., Gullans, S. R., & Feany, M. Β. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg265 · Cited by 113
Self-citationTau and src family tyrosine kinases
Lee, G. S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.002 · Cited by 111
Ghosh, S., & Feany, M. Β. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh214 · Cited by 109
Self-citationcdc2 links the Drosophila cell cycle and asymmetric division machineries
Tio, M., Udolph, G., Yang, X., & Chia, W. N. (2001) · Nature · doi:10.1038/35059124 · Cited by 102
Inhibition of cellular growth and proliferation by dTOR overexpression in Drosophila
Hennig, K. M., & Neufeld, T. P. (2002) · genesis · doi:10.1002/gene.10139 · Cited by 97
Increased p27, an essential component of cell cycle control, in Alzheimer's disease
Ogawa, O., Lee, H., Zhu, X., Raina, A. K., Harris, P. L. R., Castellani, R. J., Perry, G. L., & Smith, M. A. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00042.x · Cited by 96
Insulin Promotes Rat Retinal Neuronal Cell Survival in a p70S6K-dependent Manner*
Wu, X., Reiter, C. E. N., Antonetti, D., Kimball, S., Jefferson, L., & Gardner, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312397200 · Cited by 88
Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain
Li, X., An, W.-L., Alafuzoff, I., Soininen, H., Winblad, B., & Pei, J.-J. (2004) · NeuroReport · doi:10.1097/00001756-200410050-00019 · Cited by 84
In Vivo Viability of Postmitotic Purkinje Neurons Requires pRb Family Member Function
Feddersen, R. M., Clark, H. B., Yunis, W. S., & Orr, H. T. (1995) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1995.1014 · Cited by 70
When parsimony backfires: Neglecting DNA repair may doom neurons in Alzheimer's disease
Nouspikel, T., & Hanawalt, P. C. (2003) · BioEssays · doi:10.1002/bies.10227 · Cited by 69
Gunn‐Moore, F. J., WILLIAMS, A. G., Toms, N. J., & Tavaré, J. M. (1997) · Biochemical Journal · doi:10.1042/bj3240365 · Cited by 58
Nobukuni, T., & Thomas, G. (2004) · Novartis Foundation symposium · doi:10.1002/0470869976.ch9 · Cited by 57
Ferrer, I., Blanco, R. E., Carmona, M., & Puig, B. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00348.x · Cited by 50
Webber, K. M., Smith, M. A., Lee, H., Harris, P. L. R., Moreira, P. I., Perry, G. L., & Zhu, X. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20380 · Cited by 30
Cited by
Sorted by citations
Stress granules and neurodegeneration
Wolozin, B., & Ivanov, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0222-5 · Cited by 810
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Kontopoulos, E., Parvin, J. D., & Feany, M. Β. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 553
Self-citationFighting neurodegeneration with rapamycin: mechanistic insights
Bové, J., Martínez‐Vicente, M., & Vila, M. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3068 · Cited by 533
Metadata
- Authors
- Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B.
- Affiliations
- Brigham and Women's Hospital (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 16
- Issue
- 3
- Pages
- 230-241
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W2064587868
- Cited by
- 266
- References
- 52
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 14 · 2017: 9 · 2016: 10 · 2015: 18 · 2014: 17 · 2013: 16 · 2012: 18
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Current Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-19790, AG88001, R01AG019790)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurobiology and Insect Physiology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- tauopathy, neurodegeneration, TOR signaling, cell cycle re-entry, postmitotic neurons, tau phosphorylation, apoptosis, Alzheimer's disease, Drosophila model, therapeutic target
- MeSH terms
- Animals, Cell Cycle, Drosophila, Enzyme Activation, Immunohistochemistry, Neurons, Protein Kinases, Blotting, Western, Signal Transduction, Apoptosis, Phosphatidylinositol 3-Kinases, In Situ Nick-End Labeling, Tauopathies, Drosophila Proteins, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
